Parotid Tumors Key Players Resort to Novel Innovation in Treatment to Increase Market Share 2023

Market Scenario
According to a new report by Market Research Future (MRFR), the market for global parotid tumors is anticipated to expand at 7.1 % CAGR during the assessment period (2017-2023) owing to the growing prevalence of cancer. The parotid glands are prone to parotitis, injury, fibrous reaction, parotid tumors, and cancers. Parotid tumors are abnormal growth within the salivary gland and can be both cancerous as well as non-cancerous. They are caused by liver cirrhosis, abdominal surgery, salivary gland infections, dehydration, salivary duct stones, and metastasis of cancer.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5678
Drivers and Constraints Affecting the Market
The human body consists of two parotid glands on either side of the face. The growth of the tumors are generally slow and benign, but in seldom cases, the growth can be malignant. Increasing consumption of alcohol, growing liver cirrhosis, and increasing prevalence of cancer are some of the major factors driving the market over the assessment period. With the growing demand for advanced technologies, government support and initiatives, and the presence of growing market players, the market for parotid tumor is anticipated to expand at a staggering rate over the review period. For instance, according to Cancer Research U.K., over 14.1 million cancer cases were diagnosed in the year 2014. According to the national cancer institute, over 14.5 million cancer cases went undiagnosed in the year 2014. Such statistics have pushed the number of cancer cases and are likely to spur the market growth over the review period.
However, complications such as facial nerve paralysis, hemorrhage or hematoma, infection, cosmetic deformity, and others arising after the required treatment are supposed to hinder the growth of the global parotid tumor market.
Global Parotid Tumor Market: Segmental Analysis
Globally, the parotid tumor market has been segmented on the basis of treatment, type, diagnosis, and end-users.
The market has been segmented into Warthin's tumor, pleomorphic adenoma, pleomorphic adenoma, and cancerous/malignant tumor based on type. In most cases, parotid tumors are benign, but in seldom cases the tumors are cancerous. Pleomorphic Adenoma is the most common type of benign parotid tumor which is also termed as benign mixed tumor. A pleomorphic adenoma might grow if not removed or left untreated.
The market has been segmented into removal of lymph node, parotidectomy, radiation therapy, reconstructive surgery, and chemotherapy based on treatment. Surgical procedures require complete or partial removal of parotid gland; a common procedure being parotidectomy.
The market has been segmented into X-ray, CT scan, MRI, ultrasound, fine needle aspiration cytology (FNAC), sialography, and others based on diagnosis.
The market has also been segmented into specialty centers, hospitals, and research centers based on end-users.
Industry News
Atlantic Health System’s new Atlantic HPV Center will begin a study to determine whether an innovative combination of immuno-oncology treatments is safe, shows preliminary efficacy and provokes an anticancer immune system response in patients with recurrent or metastatic human papillomavirus (HPV) associated head and neck squamous cancer. Recent evidence proves that several cases of squamous head and neck cancer which was previously caused due to smoking might now be caused by sexually transmitted HPV.
Competition Analysis
The prominent players operating the market for parotid tumors are Novartis AG, Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services LLC, Bayer AG, Hoffmann-La Roche Ltd, Merck & Co. Inc., Eli Lilly & Co, and others.

Table of Content: Key Points
1. Report Prologue
2. Market Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Global Parotid Tumors Market, By Type
7. Global Parotid Tumors Market, By Diagnosis
8. Global Parotid Tumors Market, By Treatment
…Continued
Access full report now: https://www.marketresearchfuture.com/reports/parotid-tumors-market-5678
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.